TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 54 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,925,000 | -15.7% | 1,221,979 | -19.9% | 0.00% | 0.0% |
| Q3 2016 | $5,845,000 | -5.1% | 1,526,146 | +6.5% | 0.00% | 0.0% |
| Q2 2016 | $6,161,000 | -0.4% | 1,432,702 | +7.2% | 0.00% | 0.0% |
| Q1 2016 | $6,188,000 | -68.4% | 1,336,411 | -31.5% | 0.00% | -80.0% |
| Q4 2015 | $19,556,000 | +25.6% | 1,949,742 | -6.6% | 0.01% | +25.0% |
| Q3 2015 | $15,571,000 | -75.3% | 2,087,330 | +57.2% | 0.00% | -73.3% |
| Q2 2015 | $62,972,000 | +38.9% | 1,327,405 | +7.3% | 0.02% | +36.4% |
| Q1 2015 | $45,347,000 | +5.2% | 1,237,628 | +14.0% | 0.01% | 0.0% |
| Q4 2014 | $43,115,000 | +315.8% | 1,085,742 | +108.9% | 0.01% | +266.7% |
| Q3 2014 | $10,369,000 | +44.2% | 519,734 | -2.5% | 0.00% | +50.0% |
| Q2 2014 | $7,189,000 | +64.2% | 532,945 | +32.5% | 0.00% | +100.0% |
| Q1 2014 | $4,379,000 | -14.2% | 402,148 | +6.5% | 0.00% | -50.0% |
| Q4 2013 | $5,104,000 | +36.0% | 377,484 | +14.4% | 0.00% | +100.0% |
| Q3 2013 | $3,754,000 | +83.1% | 329,886 | +13.1% | 0.00% | 0.0% |
| Q2 2013 | $2,050,000 | – | 291,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 600,000 | $2,142,000 | 0.14% |
| Tekla Capital Management LLC | 859,322 | $3,068,000 | 0.12% |
| DOW CHEMICAL CO /DE/ | 65,000 | $232,000 | 0.08% |
| Candriam S.C.A. | 495,613 | $1,769,000 | 0.03% |
| A.R.T. Advisors, LLC | 174,335 | $622,000 | 0.02% |
| Baker Brothers Advisors | 935,000 | $3,338,000 | 0.02% |
| FLAGSHIP HARBOR ADVISORS, LLC | 29,400 | $104,000 | 0.02% |
| Alambic Investment Management, L.P. | 17,804 | $64,000 | 0.02% |
| Teton Advisors, Inc. | 44,000 | $157,000 | 0.01% |
| Man Group plc | 737,715 | $2,634,000 | 0.01% |